ArticleJournal of cancer research and clinical oncology2022

Adjuvant chemotherapy following combined induction chemotherapy and concurrent chemoradiotherapy improves survival in N2-3-positive nasopharyngeal carcinoma patients.

Hao-Yun Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.